Top Markets
Coin of the day
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Classement en actions #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Prix de l'action
$5.34
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$2.59M
Changement (1 jour)
-11.00%
Changement (1 an)
313.95%
Pays
US
Échange Jupiter Neurosciences, Inc. (JUNS)

Catégorie

Le prix JUNS avec la capitalisation boursière de B
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
JUNS
$5.34
Capitalisation boursière de Jupiter Neurosciences, Inc.(JUNS)
Capitalisation boursière: $2.59M
En August 2026, Jupiter Neurosciences, Inc. a une capitalisation boursière de $2.59M. Cela fait de Jupiter Neurosciences, Inc. la 36527th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Jupiter Neurosciences, Inc. du 2024 au 2026
JUNS par rapport au top 5 des plus populaires stocks
Prix pour JUNS L’actif B La capitalisation boursière de B Résultats
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$11,248,311 $2.59M
$5.452T +210,642,429.22%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$9,263,824 $2.59M
$4.490T +173,479,751.48%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$8,587,892 $2.59M
$4.162T +160,821,839.37%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$7,585,042 $2.59M
$3.676T +142,041,876.72%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$5,845,143 $2.59M
$2.833T +109,459,500.50%